Eledon Pharmaceuticals, Inc. Share Price
NASDAQ: ELDN | Small CapEledon Pharmaceuticals, Inc. Stock Performance
Open $3.50 | Prev. Close $3.44 | Circuit Range N/A |
Day Range $3.44 - $3.69 | Year Range $1.37 - $4.51 | Volume 52,484 |
Average Traded $3.53 |
Eledon Pharmaceuticals, Inc. Share Price Today
As of 9 August 2026, Eledon Pharmaceuticals, Inc.'s share price is $3.69. The stock opened at $3.50, compared to its previous close of $3.44. During today's trading session, Eledon Pharmaceuticals, Inc.'s share price traded between $3.44 and $3.69, with an average price of $3.57. Over the past 52 weeks, the stock has recorded a high of $4.51 and a low of $1.37. In terms of performance, Eledon Pharmaceuticals, Inc.'s share price has risen by 41.11% over the last six months and is up 41.92% on a year-on-year basis.
Eledon Pharmaceuticals, Inc. Share Price Chart
Eledon Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $301.98M | PE Ratio (TTM) -7.10 | Dividend Yield N/A |
EPS (TTM) $-0.52 | Revenue (TTM) N/A | Return On Equity (TTM) -56.26% |
Profit Margin N/A | Debt to Equity 0.23 | Quarterly Earnings Growth YoY 7.85% |
Eledon Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Eledon Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Eledon Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.48 | $3.69 | +9.50% |
Jul 2026 | $4.00 | $3.37 | -14.25% |
Jun 2026 | $3.72 | $3.93 | +2.88% |
May 2026 | $3.62 | $3.82 | +5.23% |
Apr 2026 | $3.10 | $3.63 | +17.86% |
Mar 2026 | $2.57 | $3.08 | +17.78% |
Feb 2026 | $2.17 | $2.62 | +19.41% |
Jan 2026 | $1.52 | $2.19 | +45.51% |
Dec 2025 | $1.60 | $1.50 | -7.67% |
Nov 2025 | $4.50 | $1.63 | -62.27% |
Oct 2025 | $2.61 | $4.32 | +66.15% |
Sep 2025 | $2.58 | $2.60 | +0.00% |
ELDN Share Price FAQs
What is Eledon Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Eledon Pharmaceuticals, Inc. stock?
What is ELDN's market capitalisation today?
What is ELDN's net income for the last quarter?
What is the 5 year returns of ELDN?
What is the high & low stock price of ELDN today?
Can I buy ELDN shares in India?